Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
23-NET-01-VMT-PMC(VMT-alpha-NET-T101): A Phase I/IIa First-in-Human Study of [212Pb]VMT-alpha-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors
Anthony, Lowell
(PI)
Markey Cancer Center / Cancer Research Priority Initiative
Overview
Grants and Contracts Details
Status
Active
Effective start/end date
6/22/23
→
6/22/25
Funding
Viewpoint Molecular Targeting Incorporated:
$68,956.00
View all
View less